Summary of the clinical advantages and application of DaliRasheng (Keweike) in the treatment of insomnia

Daridorexant is a new oral dual orexin receptor antagonist (DORA), which regulates arousal status by specifically blocking Orexin-1 and Orexin-2 receptors, thereby improving insomnia symptoms. Compared with traditional benzodiazepines, Daliramen has the advantages of non-dependence, rapid onset of action, and significant improvement in sleep structure, making it a new option that has attracted much attention in the treatment of insomnia.

Pharmacological effects and mechanisms of action

The occurrence of insomnia is closely related to the overactivity of the arousal system. DaliRazen reduces the arousal activity of the central nervous system by selectively inhibiting Orexin neuronal signals without directly inhibiting GABA neurons. This mechanism allows it to improve the time it takes to fall asleep and extend the total sleep time while reducing daytime sleepiness and cognitive function impairment, reflecting high safety and tolerability. Compared with benzodiazepines, this specific mechanism is more in line with the regulation principle of the human body's natural sleep-wake rhythm.

Clinical research and efficacy advantages

Clinical trials have shown that DaliRasen can significantly shorten the sleep onset latency (Sleep Onset Latency, SOL) and prolong the total sleep time (Total Sleep Time, TST) in patients with insomnia. In a number of randomized, double-blind controlled studies, patients experienced accelerated sleep onset and reduced nighttime awakenings within one week of taking the drug, while improving next-day alertness and daytime functional performance. In addition, compared with traditional sleeping pills, Dalilaysan is well tolerated, with most adverse reactions being mild to moderate headache, fatigue or dry mouth, and drug dependence and tolerance problems are significantly reduced, which provides a theoretical basis for long-term use.

Application scenarios and patient benefits

DaliRasen is suitable for patients with moderate to severe primary insomnia, especially those who have poor tolerance to benzodiazepines or are worried about dependence. Among elderly patients, DaliRasen can effectively improve sleep quality while reducing safety risks such as falls and cognitive impairment. For insomnia patients with anxiety or mild depression, DaliRasen can also be used as part of a comprehensive treatment plan to indirectly improve mood and quality of life by improving night's sleep.

Medication plan and safety management

Dalilaysan is an oral preparation. It is recommended to take it 30 minutes before going to bed, once a day. During medication, care should be taken to avoid contact with strongCYP3A4Inhibitors or inducers should be used together to avoid affecting the blood concentration of the drug. Clinically, it is recommended that patients undergo short-term evaluation at the initial stage to observe efficacy and tolerance before deciding whether to use it long-term. At the same time, patients should incorporate good sleep hygiene habits, such as fixing their sleep schedule, reducing blue light exposure before bed, and avoiding caffeine intake, to further improve the efficacy.

Long-term applications and prospects

With its strong targeting, low side effects and non-dependence, DaliRasen provides a new option for the treatment of insomnia. Compared with traditional sleeping pills, it can improve sleep quality while maintaining daytime cognitive function, providing a safe and effective treatment solution for middle-aged and elderly patients and people with long-term insomnia. In the future, with the accumulation of more long-term follow-up data, DaliRasen is expected to become a first-line drug in the management of insomnia and provide a basis for personalized treatment.

In general, DaliRasen shows clinical advantages in the treatment of insomnia such as rapid onset of action, improvement of sleep structure, high safety and low dependence. Its specific Orexin receptor antagonistic mechanism not only effectively improves falling asleep and maintaining sleep, but also reduces common side effects of traditional drugs, providing a safer and sustainable treatment option for insomnia patients. In clinical application, through rational use of medication, combined with sleep hygiene intervention and individualized management, DaliRasen can significantly improve patients' sleep quality and living standards, reflecting its important position in modern insomnia treatment.

Reference materials:https://www.drugs.com/